Drugs & Medications

Ketamine’s Long-Lasting Antidepressant Effects via “Trapping” in NMDA Receptors & LHb

by

Researchers uncover a surprising molecular mechanism that explains ketamine’s exceptionally long-lasting antidepressant effects. Key Facts: Ketamine’s antidepressant effects last for days after its concentration drops to low, ineffective levels only an hour after administration. This contrasts starkly with ketamine’s short 13-minute half-life in the body. Ketamine continues blocking NMDA receptors and suppressing activity in the …

Read more

Antidepressants & Antibiotic Resistance: New Model Reveals Concerning Impact

by

Researchers have discovered that several commonly prescribed antidepressants can promote antibiotic resistance and persistence in E. coli bacteria. This concerning finding implicates yet another widely used class of pharmaceuticals in exacerbating the global antibiotic resistance crisis. Key Facts: Antidepressants including sertraline and duloxetine were found to significantly increase E. coli’s resistance to multiple antibiotics like …

Read more

Best Antidepressants for Preventing Relapse in Major Depression (Latest Research)

by

Researchers conducted a comprehensive analysis comparing 20 antidepressants to identify the most effective options for preventing relapse in patients with major depressive disorder (MDD). Their findings suggest desvenlafaxine, paroxetine, venlafaxine and vortioxetine balance efficacy and tolerability best for maintenance treatment. Key Facts: The analysis included 34 high-quality clinical trials with over 9,300 patients total. All …

Read more

Cognitive Enhancement with Smart Drugs to Optimize Brain Performance? Exploring the Potential

by

Researchers explore various drug compounds and their potential to enhance human cognition, including attention, learning, and higher-order thinking. While some progress has been made, many questions remain. Key Facts: Several drug compounds show potential to mildly enhance some cognitive functions like attention, learning, and memory. These include stimulants, wakefulness agents, and compounds that affect memory …

Read more

Revolutionizing Depression Treatment: Novel Rapid-Acting Antidepressants & Emerging Drug Targets

by

Major depressive disorder (MDD) is a global health crisis affecting over 300 million people. While available antidepressants help some patients, treatment is far from satisfactory for many. Exciting research into rapid-acting agents like ketamine and psilocybin combined with exploration of novel drug targets finally offers real hope for transformational change in how depression is treated. …

Read more

Antidepressants for Cancer Treatment via Autophagy Modulation?

by

Antidepressants could potentially be repurposed as anticancer agents based on emerging evidence showing they can modulate autophagy—a process cancer cells rely on for growth and survival. Key Facts: Many antidepressants like SSRIs and TCAs have demonstrated anticancer effects in lab studies. Their mechanisms involve regulating autophagy, which plays a complex role in cancer development. Specific …

Read more

Running Therapy vs. Antidepressants: Efficacy for Depression, Anxiety, Health

by

New research finds that regular running is just as effective as antidepressants for treating depression and anxiety, and leads to better physical health outcomes. Key Facts: In a study of 141 patients, running therapy and antidepressant medication had comparable effects on rates of remission (no longer meeting diagnostic criteria) from depression/anxiety disorders. However, running led …

Read more

mGluR2/3 Inhibitors as Antidepressants: Targeting Glutamate Receptors in Depression

by

Depression affects over 300 million people globally. Current antidepressants have limited efficacy and slow onset of action. New research shows promise for compounds targeting metabotropic glutamate receptors 2 and 3 (mGluR2/3) as fast-acting antidepressants with fewer side effects. Key Facts: 1/3 of depressed patients are treatment-resistant with current antidepressants mGluR2/3 inhibitors show robust, rapid (within …

Read more

Optimizing Escitalopram (Lexapro) Dosage with CYP2C19 Enzyme Genetics & Body Weight

by

Researchers have made strides towards enabling personalized dosing for the commonly prescribed antidepressant escitalopram. Using robust clinical trial data, they developed an innovative population pharmacokinetics model that elucidates the impact of patient genetics and physiology. Key Facts: Model based on data from over 170 healthy Chinese adults receiving single escitalopram doses Identified CYP2C19 liver enzyme …

Read more

Prescription Drugs & Weight Gain: Which Medications Make People Fat?

by

Medications are meant to treat medical conditions and improve health, but some can have the unintended consequence of weight gain, which can then worsen other health risks. Understanding which medications tend to cause weight gain and the mechanisms behind this effect can help patients and doctors make informed treatment decisions. Key Facts: Medications for diabetes, …

Read more

+ Load more